Pharma & Biotech
Integumen's digital revolution builds momentum
Amryt Pharma: US deal set to transform the orphan drug company
Advanced Onco gearing up for commercialisation of its LIGHT proton beam therapy system
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.